-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Humacyte, Raises Price Target to $0.6

Benzinga·11/11/2026 15:20:23
Listen to the news
Barclays analyst Christopher Pasquale maintains Humacyte (NASDAQ:HUMA) with a Equal-Weight and raises the price target from $0.5 to $0.6.